Lipitor Class Action

Lipitor Class Action Lawsuits Backed by Scientific Evidence

If you’ve been diagnosed with serious side effects, you may be eligible to file a Lipitor Lawsuit

If you’ve been diagnosed with serious side effects, you may be eligible to file a Lipitor Lawsuit

If you’ve been negatively affected by Lipitor, you may be eligible to file a Lipitor Class Action. There is mounting scientific evidence that cholesterol-lowering statin drugs in general and Lipitor (atorvastatin) in particular are associated with an increased risk of diabetes mellitus.

 

A prominently reported recent study (early 2013) published in the British Medical Journal examined a million and a half health care records in Ontario.  It linked atorvastatin alone to a statin-leading “22 percent increase in the risk of new onset diabetes.”

Nevertheless, what may have slipped under the radar in some observations was a statin-wide Harvard School of Public Health analysis of medical records based in the U.K. in which, “Statin therapy was associated with 14 percent increased risk of type-2 diabetes.”  Additionally, it read, “Initiating atorvastatin and simvastatin was associated with increased risk of type 2 diabetes.”  These findings were published in the May 2013 edition of the journal Diabetes Care.

Apparently, a serious chronic illness has been among Lipitor side effects since its 1996 approval by the U.S. Food and Drug Administration.  But it wasn’t until 2012 that the FDA announced statin labeling changes to reflect the increased risk.

 

Recent studies have joined with older research pointing to the increased risk of diabetes type II (DM II), and Lipitor is one of the statins targeted as one of the statins causing DM II.  Indeed, a Lipitor class action lawsuit may very well show that Lipitor has one of the worst track records in terms of association with new-onset type-2 diabetes.

 

As the FDA announced Feb. 28, 2012, “The FDA is also aware of studies showing that patients being treated with statins may have a small increased risk of increased blood sugar levels and of being diagnosed with type 2 diabetes mellitus.  The labels will now warn healthcare professionals and patients of this potential risk.”

 

Plaintiffs in Lipitor class action lawsuits will be able to assert that the warnings were too little, and too late for too many patients and that Lipitor’s manufacturer, Pfizer, should have known about the product’s defect and should have taken precautionary steps.

 

What happened with Lipitor? A drug intended to lower “bad” cholesterol may have done more harm than good for thousands of sufferers – users of Lipitor and victims of any one of a number of health-threatening side effects.

 

Dr. Mary Parks, director of the FDA’s Division of Metabolism and Endocrinology Products, said in the FDA’s 2012 announcement: “We want health care professionals and patients to have the most current information on the risks of statins…”

 

Lipitor class action lawsuits will seek to hold Pfizer liable to a large number of current and former Lipitor users, and will allege, among other things, that Pfizer had not effectively disclosed risk and warning in the labeling and marketing of Lipitor.  Representation by experienced trial attorneys who handle pharmaceutical injury lawsuits can help eligible Lipitor users injured by the drug to seek maximum compensation for the injuries and losses suffered by them or by a loved one as a result of Lipitor use.

There is no consultation fee and there is no charge for our review of your case. Fill out our online form today and we will contact you. You can also call us directly at 1-800-499-6652.

Leave a Reply

?